Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' OSHITA F' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 26 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Oshita, F; Yamada, K; Nomura, I; Tanaka, G; Ikehara, M; Noda, K
      Randomized study of dose or schedule modification of granulocyte colony-stimulating factor in platinum-based chemotherapy for elderly patients with lung cancer

      ONCOLOGY REPORTS
    2. Oshita, F; Nishio, K; Kameda, Y; Mitsuda, A; Ikehara, M; Tanaka, G; Yamada, K; Nomura, I; Noda, K; Arai, H; Ito, H; Nakayama, H
      Increased expression levels of p53 correlate with good response to cisplatin-based chemotherapy in non-small cell lung cancer

      ONCOLOGY REPORTS
    3. Oshita, F; Kameda, Y; Nishio, K; Tanaka, G; Yamada, K; Nomura, I; Nakayama, H; Noda, K
      Increased expression levels of cyclin-dependent kinase inhibitor p27 correlate with good responses to platinum-based chemotherapy in non-small cell lung cancer

      ONCOLOGY REPORTS
    4. Oshita, F; Yamada, K; Nomura, I; Tanaka, G; Ikehara, M; Noda, K
      Prophylactic administration of granulocyte colony-stimulating factor when monocytopenia appears lessens neutropenia caused by chemotherapy for lung cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    5. Oshita, F; Nomura, I; Yamada, K; Kato, Y; Tanaka, G; Noda, K
      Detection of K-ras mutations of bronchoalveolar lavage fluid cells aids the diagnosis of lung cancer in small pulmonary lesions

      CLINICAL CANCER RESEARCH
    6. Oshita, F; Kato, Y; Yamada, K; Nomura, I; Sugiyama, M; Yamashita, K; Kitamura, T; Noda, K
      A feasibility study of continuous etoposide infusion combined with thoracic radiation for non-small cell lung cancer

      ONCOLOGY REPORTS
    7. Kondo, M; Oshita, F; Kato, Y; Yamada, K; Nomura, I; Noda, K
      Early monocytopenia after chemotherapy as a risk factor for neutropenia

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    8. Oshita, F; Yamada, K; Nomura, I; Noda, K
      Gene-specific damage produced by topoisomerase inhibitors in human lung cancer cells and peripheral mononuclear cells as assayed by polymerase chain reaction stop assay

      ANTICANCER RESEARCH
    9. OSHITA F; NODA K; NISHIWAKI Y; FUJITA A; KURITA Y; NAKABAYASHI T; TOBISE K; ABE S; SUZUKI S; HAYASHI I; KAWAKAMI Y; MATSUDA T; TSUCHIYA S; TAKAHASHI S; TAMURA T; SAIJO N
      PHASE-II STUDY OF IRINOTECAN AND ETOPOSIDE IN PATIENTS WITH METASTATIC NON-SMALL-CELL LUNG-CANCER

      Journal of clinical oncology
    10. YAMAMOTO N; TAMURA T; OHE Y; OSHITA F; KASAI T; KURATA T; SHINKAI T; EGUCHI K; SAIJO N
      CHRONOPHARMACOLOGY OF ETOPOSIDE GIVEN BY LOW-DOSE PROLONGED INFUSION IN LUNG-CANCER PATIENTS

      Anticancer research
    11. KATSUMATA N; EGUCHI K; FUKUDA M; YAMAMOTO N; OHE Y; OSHITA F; TAMURA T; SHINKAI T; SAIJO N
      SERUM LEVELS OF CYTOKINES IN PATIENTS WITH UNTREATED PRIMARY LUNG-CANCER

      Clinical cancer research
    12. SAKURAGI T; OSHITA F; NAGASHIMA S; KASAI T; KURATA T; FUKUDA M; YAMAMOTO N; OHE Y; TAMURA T; EGUCHI K; SHINKAI T; SAIJO N
      RETROSPECTIVE ANALYSIS OF THE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER SHOWING POOR PERFORMANCE STATUS

      Japanese Journal of Clinical Oncology
    13. OSHITA F; ARIOKA H; HEIKE Y; SHIRAISHI J; SAIJO N
      CORRELATION OF GENE-SPECIFIC DAMAGE WITH CISPLATIN BETWEEN HUMAN ADENOCARCINOMA CELLS AND PERIPHERAL-BLOOD MONONUCLEAR-CELLS ANALYZED BY POLYMERASE CHAIN REACTION-STOP ASSAY

      Japanese journal of cancer research
    14. OSHITA F; KURATA T; KASAI T; FUKUDA M; YAMAMOTO N; OHE Y; TAMURA T; EGUCHI K; SHINKAI T; SAIJO N
      PROSPECTIVE EVALUATION OF THE FEASIBILITY OF CISPLATIN-BASED CHEMOTHERAPY FOR ELDERLY LUNG-CANCER PATIENTS WITH NORMAL ORGAN FUNCTIONS

      Japanese journal of cancer research
    15. OSHITA F; KASAI T; KURATA T; FUKUDA M; YAMAMOTO N; OHE Y; TAMURA T; EGUCHI K; SHINKAI T; SAIJO N
      INTENSIVE CHEMOTHERAPY WITH CISPLATIN, DOXORUBICIN, CYCLOPHOSPHAMIDE,ETOPOSIDE AND GRANULOCYTE-COLONY-STIMULATING FACTOR FOR ADVANCED THYMOMA OR THYMIC CANCER - PRELIMINARY-RESULTS

      Japanese Journal of Clinical Oncology
    16. YAMAMOTO N; TAMURA T; MAEDA M; ANDO M; SHINKAI T; EGUCHI K; OHE Y; OSHITA F; SHIRAISHI J; KATSUMATA N; SAIJO N
      THE INFLUENCE OF AGING ON CISPLATIN PHARMACOKINETICS IN LUNG-CANCER PATIENTS WITH NORMAL ORGAN FUNCTION

      Cancer chemotherapy and pharmacology
    17. NAKASHIMA H; LIEBERMAN R; KARATO A; ARIOKA H; OHMATSU H; NOMURA N; SHIRAISHI J; TAMURA T; EGUCHI K; SHINKAI T; SASAKI Y; YAMAMOTO N; HUKUDA M; OSHITA F; OHE Y; SAIJO N
      EFFICIENT SAMPLING STRATEGIES FOR FORECASTING PHARMACOKINETIC PARAMETERS OF IRINOTECAN (CPT-11) - IMPLICATION FOR AREA UNDER THE CONCENTRATION-TIME CURVE MONITORING

      Therapeutic drug monitoring
    18. OSHITA F; YAMAMOTO N; FUKUDA M; OHE Y; TAMURA T; EGUCHI K; SHINKAI T; SAIJO N
      CORRELATION OF THERAPEUTIC OUTCOME IN NONSMALL CELL LUNG-CANCER AND DNA-DAMAGE ASSAYED BY POLYMERASE CHAIN-REACTION IN LEUKOCYTES DAMAGED IN-VITRO

      Cancer research
    19. YAMAMOTO N; TAMURA T; KARATO A; UENAKA K; EGUCHI K; SHINKAI T; OHE Y; OSHITA F; ARIOKA H; NAKASHIMA H; SHIRAISHI J; FUKUDA M; HIGUCHI S; SAIJO N
      CPT-11 - POPULATION PHARMACOKINETIC MODEL AND ESTIMATION OF PHARMACOKINETICS USING THE BAYESIAN METHOD IN PATIENTS WITH LUNG-CANCER

      Japanese journal of cancer research
    20. OSHITA F; SAIJO N
      RAPID POLYMERASE CHAIN-REACTION ASSAY TO DETECT VARIATION IN THE EXTENT OF GENE-SPECIFIC DAMAGE BETWEEN CISPLATIN-RESISTANT OR VP-16-RESISTANT AND SENSITIVE LUNG-CANCER CELL-LINES

      Japanese journal of cancer research
    21. KOGA H; EGUCHI K; SHINKAI T; TAMURA T; OHE Y; OSHITA F; SAIJO N; KONDO H; OKI K; OKURA H
      PRELIMINARY EVALUATION OF THE NEW TUMOR-MARKER, CYFRA-21-1, IN LUNG-CANCER PATIENTS

      Japanese Journal of Clinical Oncology
    22. SAIJO N; NISHIO K; KUBOTA N; KANZAWA F; SHINKAI T; KARATO A; SASAKI Y; EGUCHI K; TAMURA T; OHE Y; OSHITA F; NISHIO M
      7-ETHYL-10-[4-(1-PIPERIDINO)-1-PIPERIDINO] CARBONYLOXY CAMPTOTHECIN -MECHANISM OF RESISTANCE AND CLINICAL-TRIALS

      Cancer chemotherapy and pharmacology
    23. KOJIMA A; SHINKAI T; SOEJIMA Y; OKAMOTO H; EGUCHI K; SASAKI Y; TAMURA T; OSHITA F; OHE Y; SAIJO N
      A RANDOMIZED PROSPECTIVE-STUDY OF IMIPENEM-CILASTATIN WITH OR WITHOUTAMIKACIN AS AN EMPIRICAL ANTIBIOTIC-TREATMENT FOR FEBRILE NEUTROPENICPATIENTS

      American journal of clinical oncology
    24. SHINKAI T; ARIOKA H; KUNIKANE H; EGUCHI K; SASAKI Y; TAMURA T; OHE Y; OSHITA F; NISHIO M; KARATO A; OKAMOTO H; NAKASHIMA H; OHMATSU H; SHIRAISHI J; NOMURA N; SAIJO N
      PHASE-I CLINICAL-TRIAL OF IRINOTECAN (CPT-11), PIPERIDINO)-1-PIPERIDINO]CARBONYLOXY-CAMPTOTHECIN, AND CISPLATIN IN COMBINATION WITH FIXED-DOSE OF VINDESINE IN ADVANCED NONSMALL CELL LUNG-CANCER

      Cancer research
    25. OSHITA F; EASTMAN A
      GENE-SPECIFIC DAMAGE PRODUCED BY CISPLATIN, ORMAPLATIN AND UV-LIGHT IN HUMAN-CELLS AS ASSAYED BY THE POLYMERASE CHAIN-REACTION

      Oncology research
    26. KARATO A; SASAKI Y; SHINKAI T; EGUCHI K; TAMURA T; OHE Y; OSHITA F; NISHIO M; KUNIKANE H; ARIOKA H; OHMATSU H; NAKASHIMA H; SHIRAISHI J; SAIJO N
      PHASE-I STUDY OF CPT-11 AND ETOPOSIDE IN PATIENTS WITH REFRACTORY SOLID TUMORS

      Journal of clinical oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 10:03:21